EVO,Evotec SE | Healthcare - www.financetom.com

Healthcare

EVO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Evotec SEEVO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.

It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019.

Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Latest News >

SEGG Media Commits $2.6 Million to Veloce Media Group Investment

Jul 16, 2025

11:28 AM EDT, 07/16/2025 (MT Newswires) -- SEGG Media (SEGG), formerly known as Lottery.com ( SEGG ), announced an initial investment of 2 million pounds ($2.6 million) in London-based Veloce Media Group, a motorsport and gaming media network. A second tranche, for an undisclosed amount, is expected to close by the end of July, SEGG said Wednesday in a statement....

Morgan Stanley's Wealth Management Adds $59 Billion In Net New Assets, Total Client Assets Grow To $6.5 Trillion (UPDATED)

Jul 16, 2025

Editor’s Note: The Total Client Assets numbers has been updated Morgan Stanley ( MS ) reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating the consensus of $2.02. Net earnings increased to $3.54 billion from $3.08 billion. The U.S. bank reported revenue of $16.79 billion, up 12% year over year, beating the consensus of $16.11 billion. Morgan Stanley's...

Research Alert: CFRA Maintains Buy Opinion On Shares Of First Horizon Corporation

Jul 16, 2025

11:25 AM EDT, 07/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $6 to $28, applying a forward P/E of 14.3x our 2026 EPS estimate, a premium to the peer average of 12.7x, as the...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...